HomeInsightsStock Comparison

Dishman Carbogen Amcis Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Dishman Carbogen Amcis Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Last Updated on: Jun 23, 2025

Key Highlights

  • The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 240.25 as of 23 Jun 14:37.
  • The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 5.3 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of OneSource Specialty Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Dishman Carbogen Amcis Ltd changed from ₹ 840.79 crore on March 2020 to ₹ 3693 crore on March 2024 . This represents a CAGR of 34.45% over 5 yearsThe Market Cap of OneSource Specialty Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Dishman Carbogen Amcis Ltd for the Mar '25 is ₹ 724.31 crore as compare to the Dec '24 revenue of ₹ 690.01 crore. This represent the growth of 4.97% The revenue of OneSource Specialty Pharma Ltd for the Mar '25 is ₹ 428.84 crore as compare to the Dec '24 revenue of ₹ 399.28 crore. This represent the growth of 7.4%.
  • The ebitda of Dishman Carbogen Amcis Ltd for the Mar '25 is ₹ 148.91 crore as compare to the Dec '24 ebitda of ₹ 147.8 crore. This represent the growth of 0.75% The ebitda of OneSource Specialty Pharma Ltd for the Mar '25 is ₹ 184.72 crore as compare to the Dec '24 ebitda of ₹ 48.08 crore. This represent the growth of 284.19%.
  • The net profit of Dishman Carbogen Amcis Ltd changed from ₹ 17 crore to ₹ 43.09 crore over 8 quarters. This represents a CAGR of 59.21% The net profit of OneSource Specialty Pharma Ltd changed from ₹ -107 crore to ₹ 98.5 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Dishman Carbogen Amcis Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of OneSource Specialty Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dishman Carbogen Amcis Ltd

  • Dishman Carbogen Amcis Limited was formerly incorporated as Carbogen Amcis (India) Limited on July 17, 2007.
  • The Company name later on was changed to Dishman Carbogen Amcis Limited effective from 27 March 2017.
  • The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
  • It has manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.

About OneSource Specialty Pharma Ltd

  • Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
  • The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
  • The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
  • Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

Dishman Carbogen Amcis Ltd News Hub

News

Dishman Carbogen Amcis' Ahmedabad facility clears USFDA inspection without observations

The inspection was conducted from 9 June to 13 June 2025. According to the company's state...

Read more

16 Jun 2025 12:15

News

Carbogen Amic AG to co-invest in its manufacturing sites in Switzerland

Dishman Carbogen Amcis' wholly owned subsidiary, CARBOGEN AMCIS AG, a pharmaceutical proce...

Read more

06 Jun 2025 18:05

News

Dishman Carbogen spurts after turnaround Q4 outcome

Consolidated net sales rose 9.41% year-on-year to Rs 716.34 crore in Q4 March 2025. Pre-ta...

Read more

22 May 2025 12:16

News

Dishman Carbogen Amcis to hold board meeting

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 21 ...

Read more

17 May 2025 14:39

News

Dishman Carbogen Amcis' Shanghai facility clears China regulatory compliance

Dishman Carbogen Amcis announced that its Shanghai facility has successfully obtained its ...

Read more

21 Apr 2025 19:33

News

Dishman Carbogen Amcis receives affirmation in credit ratings

Dishman Carbogen Amcis has received affirmation in credit ratings from India Ratings and R...

Read more

16 Apr 2025 19:56

OneSource Specialty Pharma Ltd News Hub

News

OneSource collaborates with Xbrane Biopharma AB

OneSource Specialty Pharma and Xbrane Biopharma AB, a Sweden-headquartered biotechnology c...

Read more

11 Jun 2025 09:07

News

Onesource Specialty edges higher after inking manufacturing pact with biotech firm Xbrane

Xbrane Biopharma AB is a biotechnology company. It develops biological drugs based on a pa...

Read more

11 Jun 2025 10:09

News

OneSource Specialty jumps as Bangalore facility passes USFDA check

The facility received a Voluntary Action Indicated (VAI) classification from the USFDA, fo...

Read more

10 Jun 2025 10:16

News

OneSource receives ratings action from India Ratings & Research

OneSource Specialty Pharma announced that India Ratings & Research has assigned the credit...

Read more

04 Jun 2025 12:48

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

30 Apr 2025 11:35

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

25 Jan 2025 10:23

SWOT Analysis Of Dishman Carbogen Amcis Ltd

Strength

1

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of OneSource Specialty Pharma Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Dishman Carbogen Amcis Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dishman Carbogen Amcis Ltd and OneSource Specialty Pharma Ltd

Which company has a larger market capitalization, Dishman Carbogen Amcis Ltd or OneSource Specialty Pharma Ltd?

Market cap of Dishman Carbogen Amcis Ltd is 3,816 Cr while Market cap of OneSource Specialty Pharma Ltd is 23,211 Cr

What are the key factors driving the stock performance of Dishman Carbogen Amcis Ltd and OneSource Specialty Pharma Ltd?

The stock performance of Dishman Carbogen Amcis Ltd and OneSource Specialty Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dishman Carbogen Amcis Ltd and OneSource Specialty Pharma Ltd?

As of June 23, 2025, the Dishman Carbogen Amcis Ltd stock price is INR ₹243.4. On the other hand, OneSource Specialty Pharma Ltd stock price is INR ₹2028.3.

How do dividend payouts of Dishman Carbogen Amcis Ltd and OneSource Specialty Pharma Ltd compare?

To compare the dividend payouts of Dishman Carbogen Amcis Ltd and OneSource Specialty Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions